Ontex Q3 2023 results: Sales and adjusted EBITDA growth continues;
Leverage down to 3.6 times
Regulated information
- Revenue up 10% like-for-like, by sustaining prices at
H1 level, and growing volume year on year;
- Adjusted EBITDA margin of 9.5% for Core Markets, up
4.0pp, driven by operational efficiencies and sustained solid
prices;
- Strong contribution from Emerging Markets, while making
progress on divestments;
- Leverage ratio reduced over Q3 from 4.5 times to 3.6
times;
- Full year outlook confirmed.
Q3 2023 results
- Revenue [1] of Core Markets was €457 million, up 10%
like for like versus Q3 2022. Prices were up 8% year on year and
remained in line with H1. Volume and mix was up 3% year on year,
driven by adult care sales in Europe, and baby pants in North
America. Including a 5% adverse forex effect, total revenue was up
6% year on year.
- Adjusted EBITDA [1] of Core Markets was €44 million, up
€20 million year on year, and slightly higher than in the
previous quarter, thanks to relentless focus on delivering 5%
operational efficiencies. Sustained solid pricing contributed €33
million year on year, helping to offset the additional year-on-year
cost inflation of €13 million and to manage the highly negative
forex impact of €21 million. The adjusted EBITDA margin rose to
9.5%, up 4.0pp year on year. The operating profit was €29 million,
compared to €3 million in 2022, reflecting the adjusted EBITDA
increase.
- Total Group revenue was €568 million, equally up 10%
like for like. Adjusted EBITDA came in at €58 million, including a
strong contribution from the discontinued operations (Emerging
Markets division), mainly from Brazil. The adjusted EBITDA margin
rose to 10.3%, up 4.8pp versus Q3 last year.
- Net debt for the Total Group ended at €652 million end
of September, a slight decrease from the €658 million at the start
of the quarter, which combined with the adjusted EBITDA
improvement, led to a significant leverage ratio reduction from 4.5
times to 3.6 times.
2023 Outlook
Ontex confirms and further refines its 2023
outlook, expecting:
- Revenue of Core Markets, to grow by high single-digit,
consolidating the improvement realized in 2022 and further
balancing the portfolio;
- Adjusted EBITDA margin for Core Markets in the high end
of its previously iterated range of 8% to 10%, with Q4 margin
expected at around 10%, based on continued strong delivery of the
cost transformation plan;
- Discontinued operations (Emerging Markets) to further
contribute positively to adjusted EBITDA and free cash flow;
- Leverage to reduce further from the 3.6 times realized
end of September, while investing in the company turnaround with
capex at close to 5% of revenue.
CEO quote
Gustavo Calvo Paz, Ontex’s CEO, said “The
excellent set of numbers we have posted for Q3 represent another
very encouraging quarter in Ontex’s turnaround. I am particularly
pleased that the Group’s leverage has now recovered to less than
half of the peak of a year ago, and on track to meet our ambitions,
on the back of the increase in EBITDA. Against this backdrop, we
have accelerated our core market investment plans which are key to
operational excellence, margin improvement and driving future
growth.”
[1] Reported P&L figures, represent
continuing operations, i.e. Core Markets, only. As from 2022,
Emerging Markets are reported as assets held for sale and
discontinued operations, following the strategic decision to divest
these businesses.
Unless otherwise indicated, all comments in this document on
changes are on a year-on-year basis and for revenue specifically on
a like-for-like (LFL) basis (at constant currencies and scope and
excluding hyperinflation effects). Definitions of Alternative
Performance Measures (APMs) can be found further in the
document.
Key Q3 2023 financials
Key indicators
Key
indicators |
Third Quarter |
First 9 Months |
in € million |
2023 |
2022 |
% |
% LFL |
2023 |
2022 |
% |
% LFL |
Core Markets
(continuing operations) |
Revenue |
456.9 |
431.8 |
6% |
+10% |
1,348.7 |
1,212.4 |
11% |
13% |
Baby Care |
202.3 |
194.2 |
4% |
+9% |
598.9 |
548.6 |
9% |
11% |
Adult Care |
185.0 |
171.6 |
8% |
+14% |
544.9 |
477.3 |
14% |
17% |
Feminine Care |
61.0 |
57.0 |
7% |
+9% |
184.0 |
162.3 |
13% |
14% |
Adj. EBITDA |
43.6 |
24.0 |
81% |
|
127.4 |
63.7 |
100% |
|
Adj. EBITDA margin |
9.5% |
5.6% |
+4.0pp |
|
9.4% |
5.3% |
+4.2pp |
|
Operating profit/(loss) |
29.3 |
3.4 |
+764% |
|
64.9 |
(81.1) |
+180% |
|
Emerging
Markets (discontinued operations) [1] |
Revenue |
111.0 |
206.4 |
-46% |
+8% |
448.1 |
577.5 |
-22% |
+13% |
Adj. EBITDA |
14.8 |
11.0 |
+34% |
|
37.6 |
20.7 |
+81% |
|
Adj. EBITDA margin |
13.3% |
5.4% |
+8.0pp |
|
8.4% |
3.6% |
+4.8pp |
|
Operating
profit/(loss) |
12.3 |
10.7 |
+15% |
|
9.5 |
(48.6) |
+120% |
|
Total Group
[1] |
Revenue |
567.9 |
638.1 |
-11% |
+10% |
1,796.8 |
1,789.9 |
+0% |
+13% |
Adj. EBITDA |
58.4 |
35.1 |
+66% |
|
165.0 |
84.5 |
+95% |
|
Adj. EBITDA margin |
10.3% |
5.5% |
+4.8pp |
|
9.2% |
4.7% |
+4.5pp |
|
Operating
profit/(loss) |
41.6 |
14.1 |
+196% |
|
74.4 |
(129.7) |
+157% |
|
Net financial debt [2] |
|
|
|
|
651.7 |
867.4 |
-25% |
|
Leverage ratio [2] |
|
|
|
|
3.6x |
6.4x |
(2.8x) |
|
Core Markets (continuing operations) year on year
evolution
Revenue |
|
|
2022 |
Volume/ |
Price |
2023 |
Forex |
2023 |
in €
million |
|
|
|
mix |
|
LFL |
|
|
Third
Quarter |
|
|
431.8 |
+12.2 |
+33.0 |
476.9 |
-20.0 |
456.9 |
First 9
Months |
|
|
1,212.4 |
+19.0 |
+142.3 |
1,373.6 |
-24.9 |
1,348.7 |
Adj.
EBITDA |
2022 |
Volume/ |
Raw |
Operating |
Operating |
SG&A/ |
Forex |
2023 |
in €
million |
|
mix/price |
materials |
costs |
savings |
Other |
|
|
Third
Quarter |
24.0 |
+33.7 |
-4.6 |
-7.5 |
+20.3 |
-1.2 |
-21.2 |
43.6 |
First 9
Months |
63.7 |
+150.1 |
-74.3 |
-31.2 |
+55.5 |
-2.9 |
-33.6 |
127.4 |
[1] Emerging Markets and Total Group year-on-year
comparison is affected by the divestment of the Mexican business
activities as of May 2023. The LFL comparison is corrected for the
scope reduction.
[2] Balance sheet data are compared to start of the
period, i.e. September 2023 versus December 2022.
Q3 2023 business review of Core Markets
(continuing operations)
Revenue
Revenue was €457 million, up
10% like for like versus the third quarter of 2022, driven by
sustained pricing and volume growth. Adult care revenue was up 14%
like for like, while in baby care and in feminine care 9%
like-for-like growth was recorded. Forex had a significantly
adverse effect, reducing total revenue growth to 6% year on
year.
Volume and mix had a 3% growth
impact. In Europe market demand remained subdued overall, albeit
better than in the first half of the year, while retail brand
volumes were up year on year and thus continued to gain share.
Volume growth was most pronounced in adult care, where retail
brands had been underperforming the market in the year so far. This
largely reflected Ontex’s own sales volumes in Europe with strong
growth of adult care products in Southern Europe and of baby pants
in Western and Central Europe. Sales volumes in feminine care
remained lower. In North America volumes were back up by double
digits thanks to customer gains and following the customer
destocking affecting the first half of the year.
Prices were up 8% on average
compared to the third quarter of 2022, reflecting increases across
categories. The price increases were largely implemented in 2022,
and prices in the third quarter were sustained at the levels of the
first half of the year.
Forex fluctuations had an adverse impact
of 5%. The strong year-on-year depreciation of the Russian ruble,
and to a lesser extent the US dollar and the Australian dollar,
more than offset the appreciation of the Polish zloty.
Adjusted EBITDA
Adjusted EBITDA was €44 million, up €20
million or 81% year on year, and slightly up versus the second
quarter of 2023, thanks to relentless focus on delivering 5%
operational efficiencies. Pricing helped to offset the year-on-year
cost inflation and to manage the highly negative forex impact. The
adjusted EBITDA margin rose to 9.5%, up 4.0pp year on year.
Volume and mix growth had a slight €1
million positive impact on adjusted EBITDA.
Cost transformation measures resulted in
€20 million savings, leading to a reduction of the operational cost
base by more than 5%. Procurement and supply chain initiatives, as
well as operational efficiency were the main drivers behind the
improvement.
Cost inflation continued to weigh on the
year-on-year comparison, albeit less than in the previous quarters.
Raw material costs were up by €5 million. While all raw
material indices are down compared to the third quarter of 2022,
especially those for oil-based materials, the impact on the P&L
comes with a lag. Other operating costs were up by €7 million year
on year, and also higher quarter on quarter, due to wage inflation
and rising energy costs. These also included temporary higher
energy costs in Ontex’s retained plant in Tijuana, Mexico,
following its carve-in triggered by the divestment of the main
Mexican business in the second quarter. SG&A costs were up
slightly with wage inflation as well, but remained at 9% of
revenue.
Pricing efforts contributed €33 million
year on year. While this offset the adverse forex evolution and the
additional input cost inflation versus the previous year, thanks to
continued disciplined approach, it still does not cover the
cumulative cost increase incurred since the start of the inflation
wave in 2021 in all markets and categories. Thereby careful
management of the pricing policy is required.
Forex fluctuations had a €21 million net
negative impact, reflecting the impact on the revenue, whereas the
net impact on costs was largely neutral, with the appreciation of
the Mexican peso offsetting the depreciation effect of the US
dollar.
Q3 2023 financial review of Total
Group
P&L
The operating profit (of continuing
operations) was €29 million, a significant increase versus €3
million in the third quarter of 2022, reflecting the strong
increase in adjusted EBITDA. Depreciation was €16 million, slightly
lower than in 2022 due to forex fluctuations. EBITDA adjustments
were made for a €2 million income, consisting mostly of a reversal
of impairment related to the re-activation of production
equipment.
Discontinued operations, consisting of
the Emerging Markets division, generated a revenue of €111 million,
up 8% like for like compared with last year, increasing across
geographies. Strong pricing more than offset slightly lower
volumes. Adjusted EBITDA came in at €15 million, with the largest
contribution from the Brazilian business activities. The adjusted
EBITDA margin of 13.3%, was up 8.0pp year on year. EBITDA
adjustments were made for €2 million mostly divestment-related
costs. The operating profit thereby was €12 million.
Cash and balance sheet
Net financial debt for the total Group
was €652 million at the end of September 2023, a €6 million
decrease compared to €658 million at the start of the quarter. The
increase in working capital needs came to a halt.
Active measures allowed to improve the cash conversion cycle, more
than offsetting the impact of growing sales. As in the second
quarter, capex grew to more than 4% of revenue.
The investment intensity has been raised to support the
transformation of the operations in Europe as well as the expansion
in the US. The financing cash-out was in line with the previous
year and included the semi-annual coupon payment on the fixed rate
bond.
The leverage ratio decreased further to
3.6 times from 4.5 times at the end of June 2023 and less than half
of the peak of 7.7 times in September 2022. The strong improvement
is mostly driven by the increase in adjusted EBITDA over the last
quarters.
During the quarter, an agreement was reached to
divest Ontex’s business activities in Algeria and Pakistan to two
different third parties. The finalization of these
divestments is foreseen before the end of the year. There
were no significant changes reported on the net asset value of
these entities. In the second quarter of this year the divestment
of Ontex’s Mexican business activities was closed. This deal is
still subject to post-closing adjustments, as well as a deferred
receivable of €39 million.
Additional information
Alternative Performance Measures
Alternative performance measures (non-GAAP) are
used in this press release since management believes that they are
widely used by certain investors, securities analysts and other
interested parties as supplemental measure of performance and
liquidity. The alternative performance measures may not be
comparable to similarly titled measures of other companies and have
limitations as analytical tools and should not be considered in
isolation or as a substitute for analysis of our operating results,
our performance or our liquidity under IFRS.
Like-for-like revenue (LFL)
Like-for-like revenue is defined as revenue at
constant currency excluding change in scope of consolidation or
M&A and hyperinflation impacts. The reconciliation of
like-for-like revenue can be found on page 2 of this document.
EBITDA and Adjusted EBITDA and related margins
EBITDA is defined as earnings before net finance
cost, income taxes, depreciations and amortizations. Adjusted
EBITDA is defined as EBITDA plus EBITDA adjustments. EBITDA and
Adjusted EBITDA margins are EBITDA and Adjusted EBITDA divided by
revenue.
EBITDA adjustments are made for income and
expenses that are considered by management not to relate to
transactions, projects and adjustments to the value of assets and
liabilities taking place in the ordinary course of activities of
the Group. These income and expenses are presented separately, due
to their size or nature, so as to allow users of the consolidated
financial statements of the Company to get a better understanding
of the normalized performance of the Company, and relate to:
- acquisition-related expenses;
- changes to the measurement of contingent considerations in the
context of business combinations;
- changes to the Group structure, business restructuring costs,
including costs related to the liquidation of subsidiaries and the
closure, opening or relocations of factories;
- impairment of assets and major litigations.
In the consolidated income statement these
EBITDA adjustments are composed of the following items:
- income/(expenses) related to changes to Group structure;
and
- income/(expenses) related to impairments and major
litigations.
Reconciliation of income statement |
|
|
|
Third Quarter |
|
2023 |
2022 |
in € million |
|
|
Continued |
|
Discontinued |
Total |
Continued |
Discontinued |
Total |
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
a |
456.9 |
|
111.0 |
567.9 |
431.8 |
206.4 |
638.1 |
Operating profit/(loss) |
|
|
b |
29.3 |
|
12.3 |
41.6 |
3.4 |
10.7 |
14.1 |
Depreciation and amortization |
|
|
c |
(16.3) |
|
- |
(16.3) |
(17.9) |
- |
(17.9) |
EBITDA |
|
|
d = b-c |
45.6 |
|
12.3 |
57.9 |
21.3 |
10.7 |
32.0 |
EBITDA adjustments |
|
|
g |
(2.0) |
|
2.5 |
0.4 |
2.7 |
0.4 |
3.1 |
Adjusted EBITDA |
|
|
h = d+g |
43.6 |
|
14.8 |
58.4 |
24.0 |
11.0 |
35.1 |
Adjusted EBITDA margin |
|
|
i = h/a |
9.5% |
|
13.3% |
10.3% |
5.6% |
5.4% |
5.5% |
More information on the EBITDA adjustments can
be found on page 4 of the press release.
Reconciliation of income statement |
|
|
|
First 9 Months |
|
2023 |
2022 |
in € million |
|
|
Continued |
|
Discontinued |
Total |
Continued |
Discontinued |
Total |
|
|
|
|
|
|
|
|
|
|
Revenue |
|
|
a |
1,348.7 |
|
448.1 |
1,796.8 |
1,212.4 |
577.5 |
1,789.9 |
Operating profit/(loss) |
|
|
b |
64.9 |
|
9.5 |
74.4 |
(81.1) |
(48.6) |
(129.7) |
Depreciation and amortization |
|
|
c |
(52.0) |
|
- |
(52.0) |
(52.4) |
- |
(52.4) |
EBITDA |
|
|
d = b-c |
116.9 |
|
9.5 |
126.4 |
(28.7) |
(48.6) |
(77.3) |
EBITDA adjustments |
|
|
g |
10.5 |
|
28.0 |
38.6 |
92.5 |
69.4 |
161.8 |
Adjusted EBITDA |
|
|
h = d+g |
127.4 |
|
37.5 |
165.0 |
63.7 |
20.7 |
84.5 |
Adjusted EBITDA margin |
|
|
i = h/a |
9.4% |
|
8.4% |
9.2% |
5.3% |
3.6% |
4.7% |
Net financial debt and leverage ratio
Net financial debt is calculated by adding
short-term and long-term debt and deducting cash and cash
equivalents. The leverage ratio is defined as the net financial
debt divided by the adjusted EBITDA for the last twelve months
(LTM).
Reconciliation of net financial debt |
September 30, 2023 |
|
December 31, 2022 |
in € million |
Continued |
Discontinued |
Total |
|
Continued |
Discontinued |
Total |
Non-current interest-bearing debts |
A |
668.7 |
15.0 |
683.7 |
|
891.7 |
16.8 |
908.5 |
Current interest-bearing debts |
B |
121.2 |
3.8 |
124.9 |
|
145.4 |
22.2 |
167.6 |
Cash and cash equivalents |
C |
96.6 |
60.4 |
157.0 |
|
149.1 |
59.7 |
208.7 |
Net financial debt |
D = A+B-C |
693.2 |
(41.6) |
651.7 |
|
888.1 |
(20.7) |
867.4 |
Adjusted EBITDA (LTM)* |
E |
|
|
181.8 |
|
|
|
135.7 |
Leverage ratio |
F = D/E |
|
|
3.6x |
|
|
|
6.4x |
* The LTM (last twelve months) adjusted EBITDA
excludes the contribution of the Mexican business activities,
divested in the second quarter of 2023.
Disclaimer
This report may include forward-looking
statements. Forward-looking statements are statements regarding or
based upon our management’s current intentions, beliefs or
expectations relating to, among other things, Ontex’s future
results of operations, financial condition, liquidity, prospects,
growth, strategies or developments in the industry in which we
operate. By their nature, forward-looking statements are subject to
risks, uncertainties and assumptions that could cause actual
results or future events to differ materially from those expressed
or implied thereby. These risks, uncertainties and assumptions
could adversely affect the outcome and financial effects of the
plans and events described herein.
Forward-looking statements contained in this
report regarding trends or current activities should not be taken
as a report that such trends or activities will continue in the
future. We undertake no obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. You should not place undue reliance on
any such forward-looking statements, which speak only as of the
date of this report.
The information contained in this report is
subject to change without notice. No re-report or warranty, express
or implied, is made as to the fairness, accuracy, reasonableness or
completeness of the information contained herein and no reliance
should be placed on it.
In most of the tables of this report, amounts
are shown in € million for reasons of transparency. This may give
rise to rounding differences in the tables presented in the
report.
Corporate information
The above press release and related financial
information of Ontex Group NV for the nine months ended September
30, 2023 was authorized for issue in accordance with a resolution
of the Board on October 26, 2023.
Audio webcast
Management will host an audio webcast for
investors and analysts on October 27, 2023 at 12:00 CEST / 11:00
BST. A copy of the presentation slides will be available on
ontex.com.
Click on the link below to attend the
presentation from your laptop, tablet or mobile device. Audio will
stream through your selected device, so be sure to have headphones
or your volume turned up.
https://channel.royalcast.com/landingpage/ontexgroup/20231027_1
A full replay of the presentation will be
available at the same link shortly after the conclusion of the live
presentation.
Financial calendar
- February 8, 2024 Q4 &
full year 2023 results
- May 3,
2023 Q1
2024 results
- May 3, 2023
2024 Annual general meeting of shareholders
- July 31, 2023
Q2 & H1 2024 results
- October 24, 2023 Q3 2024
results
Enquiries
-
Investors
Geoffroy
Raskin +32 53
33 37 30
investor.relations@ontexglobal.com
-
Media
Maarten Verbanck +32 492 72 42
67
corporate.communications@ontexglobal.com
About Ontex
Ontex is a leading international provider of
personal hygiene solutions, with expertise in baby care, feminine
care and adult care. Ontex’s innovative products are distributed in
around 100 countries through leading retailer brands, lifestyle
brands and Ontex brands. Employing some 7,500 people all over the
world, Ontex has a presence in 21 countries, with its headquarters
in Aalst, Belgium. Ontex is listed on Euronext Brussels and is part
of the Bel Mid®. To keep up with the latest news, visit ontex.com
or follow Ontex on LinkedIn, Facebook, Instagram and YouTube.
ONTEX GROUP
NV
Korte Keppestraat 21 – 9320 Erembodegem (Aalst) –
Belgium 0550.880.915 RPR Ghent – Division
Dendermonde
- Q3 2023 Results Release_EN
Ontex Group NV (EU:ONTEX)
Historical Stock Chart
From Oct 2024 to Nov 2024
Ontex Group NV (EU:ONTEX)
Historical Stock Chart
From Nov 2023 to Nov 2024